These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25542597)

  • 21. Exploratory clinical trials: implementation modes & guidelines, scope and regulatory framework.
    Francillon A; Pickering G; Belorgey C
    Therapie; 2009; 64(3):149-59. PubMed ID: 19671427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.
    Azuma A
    Expert Rev Respir Med; 2010 Jun; 4(3):301-10. PubMed ID: 20524912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
    Klingsberg RC; Mutsaers SE; Lasky JA
    Respirology; 2010 Jan; 15(1):19-31. PubMed ID: 20199632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research.
    Baroke E; Gauldie J; Kolb M
    Expert Rev Respir Med; 2013 Oct; 7(5):465-78. PubMed ID: 24138691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of idiopathic pulmonary fibrosis in France: a survey of 1244 pulmonologists.
    Cottin V; Cadranel J; Crestani B; Dalphin JC; Delaval P; Israel-Biet D; Kessler R; Reynaud-Gaubert M; Valeyre D; Wallaert B; Bouquillon B; Cordier JF
    Respir Med; 2014 Jan; 108(1):195-202. PubMed ID: 24361163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [German guideline for diagnosis and management of idiopathic pulmonary fibrosis].
    Behr J; Günther A; Ammenwerth W; Bittmann I; Bonnet R; Buhl R; Eickelberg O; Ewert R; Gläser S; Gottlieb J; Grohé C; Kreuter M; Kroegel C; Markart P; Neurohr C; Pfeifer M; Prasse A; Schönfeld N; Schreiber J; Sitter H; Theegarten D; Theile A; Wilke A; Wirtz H; Witt C; Worth H; Zabel P; Müller-Quernheim J; Costabel U
    Pneumologie; 2013 Feb; 67(2):81-111. PubMed ID: 23325398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The other side of clinical trial monitoring; assuring data quality and procedural adherence.
    Williams GW
    Clin Trials; 2006; 3(6):530-7. PubMed ID: 17170037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2012 Jun; 73(6):856-64. PubMed ID: 22687813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nintedanib: a novel therapeutic approach for idiopathic pulmonary fibrosis.
    Dimitroulis IA
    Respir Care; 2014 Sep; 59(9):1450-5. PubMed ID: 24782550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials.
    du Bois RM; Nathan SD; Richeldi L; Schwarz MI; Noble PW
    Am J Respir Crit Care Med; 2012 Oct; 186(8):712-5. PubMed ID: 22798316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The web of clinical trial registration obligations: have foreign clinical trials been caught?
    Hathaway CR; Manthei JR; Haas JB; Meltzer ED
    Food Drug Law J; 2009; 64(2):261-75. PubMed ID: 19999283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A methodology for successfully producing global translations of patient reported outcome measures for use in multiple countries.
    Two R; Verjee-Lorenz A; Clayson D; Dalal M; Grotzinger K; Younossi ZM
    Value Health; 2010; 13(1):128-31. PubMed ID: 19695006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy.
    Kane RC; Farrell AT; Sridhara R; Pazdur R
    Clin Cancer Res; 2006 May; 12(10):2955-60. PubMed ID: 16707588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system.
    Ebert MA; Haworth A; Kearvell R; Hooton B; Coleman R; Spry N; Bydder S; Joseph D
    Radiother Oncol; 2008 Feb; 86(2):200-10. PubMed ID: 18077034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of a disease severity staging classification system for IPF in Japan: 20 years of experience from empirical evidence to randomized control trial enrollment.
    Homma S; Sugino K; Sakamoto S
    Respir Investig; 2015 Jan; 53(1):7-12. PubMed ID: 25542598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The big clinical trials in idiopathic pulmonary fibrosis.
    Luppi F; Spagnolo P; Cerri S; Richeldi L
    Curr Opin Pulm Med; 2012 Sep; 18(5):428-32. PubMed ID: 22759771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Searching hidden truth behind clinical trials.
    Azuma A
    Respir Investig; 2015 Jan; 53(1):1. PubMed ID: 25542596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.